ORIX vs Brown & Brown
ORIX is a sprawling Japanese conglomerate touching leasing, banking, insurance, real estate, and private equity across Asia, while Brown & Brown is a focused U.S. insurance distribution platform that's compounded earnings for decades through disciplined bolt-on acquisitions. Both are serial acquirers in financial services, but their scope and geographic concentration couldn't be more different. ORIX vs Brown & Brown examines which acquisition-driven growth model allocates capital more efficiently and which valuation better reflects the quality of earnings underneath.
ORIX is a sprawling Japanese conglomerate touching leasing, banking, insurance, real estate, and private equity across Asia, while Brown & Brown is a focused U.S. insurance distribution platform that'...
Why It's Moving
IX Stock Warning: Why Analysts See -7% Downside Risk
- AI-driven analysis flags no clear positioning signal, pointing to heightened risk as long-term support evaporates below key thresholds like $29.35.
- Multi-timeframe signals show neutral near-term outlook but weak mid-term momentum, amplifying potential drops toward $28.63 in hedging scenarios.
- Choppy conditions from divergent horizons signal investor caution, with absence of bullish triggers pushing focus on stop-loss levels around $30.06.
Analysts Rally Behind BRO's Strong Growth Path with Forecasts Pointing to Robust 2026 Upside.
- Recent analyst updates from top firms like Morgan Stanley and Truist maintain targets implying significant appreciation, driven by expected revenue surge to $5.93 billion in 2025.
- EPS forecasts for 2026 range from $4.25 to $4.91, signaling sustained profitability from organic growth and strategic acquisitions in a resilient insurance sector.
- Consensus leans toward Hold with bullish undertones from Strong Buy calls, as improving net margins to 23.48% underscore BRO's operational strength amid broader market stability.
IX Stock Warning: Why Analysts See -7% Downside Risk
- AI-driven analysis flags no clear positioning signal, pointing to heightened risk as long-term support evaporates below key thresholds like $29.35.
- Multi-timeframe signals show neutral near-term outlook but weak mid-term momentum, amplifying potential drops toward $28.63 in hedging scenarios.
- Choppy conditions from divergent horizons signal investor caution, with absence of bullish triggers pushing focus on stop-loss levels around $30.06.
Analysts Rally Behind BRO's Strong Growth Path with Forecasts Pointing to Robust 2026 Upside.
- Recent analyst updates from top firms like Morgan Stanley and Truist maintain targets implying significant appreciation, driven by expected revenue surge to $5.93 billion in 2025.
- EPS forecasts for 2026 range from $4.25 to $4.91, signaling sustained profitability from organic growth and strategic acquisitions in a resilient insurance sector.
- Consensus leans toward Hold with bullish undertones from Strong Buy calls, as improving net margins to 23.48% underscore BRO's operational strength amid broader market stability.
Investment Analysis
ORIX
IX
Pros
- ORIX has a diversified financial services portfolio with operations across Japan, the US, Asia, Europe, and Australasia, reducing geographic risk.
- The company reported steady revenue growth in 2024, increasing by 2.15% to approximately 2.87 trillion JPY, accompanied by a 1.58% rise in earnings.
- ORIX maintains a strong asset base in the US through its subsidiaries with $91.3 billion in assets under management and servicing as of mid-2025.
Considerations
- ORIX's future growth prospects are rated relatively low with challenges anticipated in accelerating revenue or earnings expansion beyond recent levels.
- The company's debt-to-equity ratio is high at about 151%, indicating leverage that could impact financial flexibility under adverse conditions.
- Its stock price has shown volatility recently, falling 5.3% from a recent all-time high, signaling potential market uncertainty or valuation risks.
Pros
- Brown & Brown demonstrated strong revenue growth of over 12% and earnings growth exceeding 14% in 2024, reflecting robust operational performance.
- The company has a diversified insurance product portfolio across commercial, public entities and personal lines, spanning multiple countries.
- Analyst sentiment is positive with a majority rating the stock as a 'Buy' and an expected price target implying over 30% upside from current levels.
Considerations
- Brown & Brown's price-to-earnings ratio is relatively elevated at 23.7x, which may imply limited valuation margin compared to peers or historical averages.
- Dividend yield is modest at 0.84%, providing limited income appeal relative to many other financial stocks.
- The stock's 52-week range shows a notable recent decline from its highs near $125 to current levels near $79, indicating market volatility or concerns.
Related Market Insights
When Inflation Stays Stubborn: The Investment Case for Pricing Power
Navigate persistent inflation with Nemo. Discover companies with strong pricing power and financial institutions benefiting from high rates. Invest in inflation-resistant baskets. Start from £1.
Aimee Silverwood | Financial Analyst
September 28, 2025
The Fed's Stubborn Stance: Why Higher Rates Create Hidden Winners
Discover how to profit from the Fed's higher-for-longer interest rate policy. Identify companies with strong balance sheets and pricing power thriving amidst rising borrowing costs.
Aimee Silverwood | Financial Analyst
July 31, 2025
Related Market Insights
When Inflation Stays Stubborn: The Investment Case for Pricing Power
Navigate persistent inflation with Nemo. Discover companies with strong pricing power and financial institutions benefiting from high rates. Invest in inflation-resistant baskets. Start from £1.
Aimee Silverwood | Financial Analyst
September 28, 2025
The Fed's Stubborn Stance: Why Higher Rates Create Hidden Winners
Discover how to profit from the Fed's higher-for-longer interest rate policy. Identify companies with strong balance sheets and pricing power thriving amidst rising borrowing costs.
Aimee Silverwood | Financial Analyst
July 31, 2025
ORIX (IX) Next Earnings Date
IX's next earnings date, covering the fiscal quarter ending June 2026, is projected for May 11, 2026, aligning with the company's historical pattern of mid-May releases for this period. This follows the prior third quarter results announced on February 9, 2026. Investors should monitor official announcements for any adjustments to this projected schedule.
Brown & Brown (BRO) Next Earnings Date
Brown & Brown (BRO) is expected to announce its next earnings report on April 27, 2026, covering the Q1 2026 quarter. The company has not officially confirmed this date, but analysts project it based on historical earnings release patterns. Analysts are currently forecasting earnings per share of approximately $1.38-$1.39 for the quarter. This earnings announcement will provide investors with updated financial performance and guidance for the remainder of 2026.
ORIX (IX) Next Earnings Date
IX's next earnings date, covering the fiscal quarter ending June 2026, is projected for May 11, 2026, aligning with the company's historical pattern of mid-May releases for this period. This follows the prior third quarter results announced on February 9, 2026. Investors should monitor official announcements for any adjustments to this projected schedule.
Brown & Brown (BRO) Next Earnings Date
Brown & Brown (BRO) is expected to announce its next earnings report on April 27, 2026, covering the Q1 2026 quarter. The company has not officially confirmed this date, but analysts project it based on historical earnings release patterns. Analysts are currently forecasting earnings per share of approximately $1.38-$1.39 for the quarter. This earnings announcement will provide investors with updated financial performance and guidance for the remainder of 2026.
Which Baskets Do They Appear In?
Inflation-Resistant Investments | Core PCE at 2.9%
The Federal Reserve's key inflation metric remained elevated at 2.9%, signaling that the fight against rising prices is ongoing. This creates a potential investment opportunity in companies that can thrive in a high-inflation, high-interest-rate environment.
Published: September 28, 2025
Explore BasketProfiting From The Fed's Firm Stance
The Federal Reserve has held interest rates steady, with Chair Jerome Powell pushing back on expectations for a near-term cut. This creates an investment opportunity in companies that can thrive in a sustained high-interest-rate environment due to strong balance sheets and pricing power.
Published: July 31, 2025
Explore BasketWhich Baskets Do They Appear In?
Inflation-Resistant Investments | Core PCE at 2.9%
The Federal Reserve's key inflation metric remained elevated at 2.9%, signaling that the fight against rising prices is ongoing. This creates a potential investment opportunity in companies that can thrive in a high-inflation, high-interest-rate environment.
Published: September 28, 2025
Explore BasketProfiting From The Fed's Firm Stance
The Federal Reserve has held interest rates steady, with Chair Jerome Powell pushing back on expectations for a near-term cut. This creates an investment opportunity in companies that can thrive in a sustained high-interest-rate environment due to strong balance sheets and pricing power.
Published: July 31, 2025
Explore BasketBuy IX or BRO in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
ORIX vs W. R. Berkley
ORIX is a Japanese financial conglomerate with significant positions in leasing, private equity, real estate, and insurance spanning multiple continents, while W. R. Berkley is a disciplined U.S. specialty insurer known for rigorous underwriting culture and a decentralized operating model that empowers individual business units. Both are capital-intensive businesses where investment returns and risk-selection discipline drive long-term value creation for shareholders. The ORIX vs W. R. Berkley comparison examines combined ratios, return-on-equity trends, and capital-allocation philosophies to show how a diversified Asian financial giant measures up against a focused American specialty insurer through an insurance hard market.
ORIX vs M&T Bank
ORIX is a Japanese financial services conglomerate with a massive and diversified balance sheet spanning leasing, banking, insurance, real estate, and infrastructure globally, earning returns from a sprawling range of asset-intensive businesses. M&T Bank is a well-regarded U.S. regional bank known for conservative credit underwriting and deep commercial banking relationships concentrated in the Mid-Atlantic and Northeast. Both deploy capital through lending and asset-based financing, and both must navigate the same interest-rate and credit-cycle pressures that define bank profitability. ORIX vs M&T Bank pits a globally diversified financial conglomerate against one of America's most respected regional banks to determine which model earns better risk-adjusted returns.
ORIX vs Fifth Third
ORIX is a Japanese financial conglomerate with tentacles in leasing, banking, real estate, and asset management across Asia and globally, while Fifth Third is a Midwest U.S. regional bank that's been methodically improving its returns through fee income diversification and expense discipline. ORIX vs Fifth Third pits an international financial services conglomerate with massive breadth against a focused American regional bank with deep community roots. This comparison unpacks how scale, geographic diversification, and business model complexity affect the valuation and risk profile of two very different financial institutions.
